Literature DB >> 29485849

Intestinal Mucin Induces More Endocytosis but Less Transcytosis of Nanoparticles across Enterocytes by Triggering Nanoclustering and Strengthening the Retrograde Pathway.

Dan Yang1,2,3, Dechun Liu1,2,3, Mengmeng Qin2,3, Binlong Chen2,3, Siyang Song1,2,3, Wenbing Dai2,3, Hua Zhang2,3, Xueqing Wang2,3, Yiguang Wang2,3, Bing He2,3, Xing Tang1, Qiang Zhang1,2,3.   

Abstract

Mucus, which is secreted by the goblet cells of enterocytes, constitutes the first obstacle encountered for the intestinal absorption of nanomedicines. For decades, mucus has simply been regarded as a physical barrier that hinders the permeation and absorption of drugs, because of its high viscosity and reticular structure, whereas the interaction of mucus ingredients with nanomedicines is usually neglected. It is unclear whether glycoproteins, as the main components of mucus, interact with nanomedicines. We also do not know how the potential interaction affects the subsequent transportation of nanomedicines through the intestinal epithelium. In this study, mucin as the key element of mucus was investigated to characterize the interaction of nanomedicines with mucus. PEG-modified gold nanoparticles (PGNPs) were fabricated as model nanoparticles. Mucin was found to adhere to the nanoparticle surface to form a corona structure and induce the clustering of PGNPs by joining particles together, demonstrating the interaction between mucin and PGNPs. In addition, two intestinal epithelia, Caco-2 (non- mucus secretion) and HT-29 (high mucus secretion), were compared to evaluate the influence of mucin on the cellular interaction of PGNPs. Amazingly, mucin altered the trafficking characteristic of PGNPs in intestinal epithelium. Both in vitro and in vivo investigations demonstrated more nanoparticles being internalized by cells due to the mucin coverage. However, mucin induced a significant reduction in the transcytosis of PGNPs across epithelial monolayers. The mechanism exploration further revealed that the "more endocytosis but less transcytosis (MELT)" effect was mainly attributed to the strengthened retrograde pathway in which more PGNPs were transported to Golgi apparatus and exocytosed back to the apical but not the basolateral side of the epithelial monolayers. The "MELT" effect endowed mucin with duality in the nanoparticle transportation. Therefore, the rational regulation based on the "MELT" effect will provide new insight into overcoming the mucus obstacle as a barrier and enhancing the oral absorption rate of nanomedicines.

Entities:  

Keywords:  corona; endocytosis; mucin; nanoclustering; retrograde pathway; transcytosis

Mesh:

Substances:

Year:  2018        PMID: 29485849     DOI: 10.1021/acsami.7b19153

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  12 in total

1.  Biocoating-A Critical Step Governing the Oral Delivery of Polymeric Nanoparticles.

Authors:  Aharon Azagury; Cameron Baptista; Kosta Milovanovic; Hyeseon Shin; Peter Morello; James Perez-Rogers; Victoria Goldenshtein; Travis Nguyen; Arianna Markel; Soham Rege; Stephanie Hojsak; Alexander Perl; Carder Jones; Megan Fife; Stacia Furtado; Edith Mathiowitz
Journal:  Small       Date:  2022-05-23       Impact factor: 15.153

Review 2.  Nanovesicles-Mediated Drug Delivery for Oral Bioavailability Enhancement.

Authors:  Yuehong Ren; Linghui Nie; Shiping Zhu; Xingwang Zhang
Journal:  Int J Nanomedicine       Date:  2022-10-17

3.  Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.

Authors:  Ying Liu; Xingmei Xie; Xuefeng Hou; Junyi Shen; Jiangpei Shi; Haizhen Chen; Yuanzhi He; Zhi Wang; Nianping Feng
Journal:  J Nanobiotechnology       Date:  2020-05-30       Impact factor: 10.435

4.  Energy-dependent endocytosis is responsible for drug transcorneal penetration following the instillation of ophthalmic formulations containing indomethacin nanoparticles.

Authors:  Noriaki Nagai; Fumihiko Ogata; Hiroko Otake; Yosuke Nakazawa; Naohito Kawasaki
Journal:  Int J Nanomedicine       Date:  2019-02-18

Review 5.  The appliances and prospects of aurum nanomaterials in biodiagnostics, imaging, drug delivery and combination therapy.

Authors:  Dan Yang; Feiyang Deng; Dechun Liu; Bo He; Bing He; Xing Tang; Qiang Zhang
Journal:  Asian J Pharm Sci       Date:  2018-09-14       Impact factor: 6.598

Review 6.  Subcellular Performance of Nanoparticles in Cancer Therapy.

Authors:  Chen-Guang Liu; Ya-Hui Han; Ranjith Kumar Kankala; Shi-Bin Wang; Ai-Zheng Chen
Journal:  Int J Nanomedicine       Date:  2020-02-05

7.  Proteomic analysis of intracellular protein corona of nanoparticles elucidates nano-trafficking network and nano-bio interactions.

Authors:  Mengmeng Qin; Jian Zhang; Minghui Li; Dan Yang; Dechun Liu; Siyang Song; Jijun Fu; Hua Zhang; Wenbing Dai; Xueqing Wang; Yiguang Wang; Bing He; Qiang Zhang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

8.  A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin.

Authors:  Irene Santalices; Carlos Vázquez-Vázquez; Manuel J Santander-Ortega; Victoria Lozano; Francisca Araújo; Bruno Sarmento; Neha Shrestha; Veronique Préat; Miguel Chenlo; Clara V Alvarez; Federico Benetti; Juan Cuñarro; Sulay Tovar; Dolores Torres; María José Alonso
Journal:  Drug Deliv Transl Res       Date:  2021-02-11       Impact factor: 4.617

Review 9.  In vivo Protein Corona Formation: Characterizations, Effects on Engineered Nanoparticles' Biobehaviors, and Applications.

Authors:  Xue Bai; Jiali Wang; Qingxin Mu; Gaoxing Su
Journal:  Front Bioeng Biotechnol       Date:  2021-03-31

10.  Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles.

Authors:  Noriaki Nagai; Fumihiko Ogata; Miyu Ishii; Yuya Fukuoka; Hiroko Otake; Yosuke Nakazawa; Naohito Kawasaki
Journal:  Int J Mol Sci       Date:  2018-07-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.